دورية أكاديمية

Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial

التفاصيل البيبلوغرافية
العنوان: Comparing the Efficacy and Safety of Galcanezumab Versus Rimegepant for Prevention of Episodic Migraine: Results from a Randomized, Controlled Clinical Trial
المؤلفون: Schwedt, Todd J., Myers Oakes, Tina M.Aff2, IDs4012002300562w_cor2, Martinez, James M., Vargas, Bert B., Pandey, Hitendra, Pearlman, Eric M., Richardson, Diane R., Varnado, Oralee J., Cobas Meyer, Michael, Goadsby, Peter J.Aff3, Aff4
المصدر: Neurology and Therapy. 13(1):85-105
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:21938253
21936536
DOI:10.1007/s40120-023-00562-w